H.C. Wainwright reiterated its Buy rating on OKYO Pharma Ltd. (NASDAQ: OKYO) with a price target of $7.00, representing significant upside potential from the current trading price of $1.10. According ...

The following is a summary of “ALS Motor Observational Telemedicine Objective Rasch-Built Assessment,” published in the ...

NNN REIT Inc. reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an earnings per share (EPS) of $0.52 compared to the forecasted $0.484. The company's revenue also ...